94 related articles for article (PubMed ID: 9397949)
1. Identification of the estrogen sensitive marker in human endometrial carcinoma RL95-2 cells.
Liu Y; Teng CT
Mol Cell Endocrinol; 1994 May; 101(1-2):167-71. PubMed ID: 9397949
[TBL] [Abstract][Full Text] [Related]
2. Local biosynthesis of estrogen in human endometrial carcinoma through tumor-stromal cell interactions.
Takahashi-Shiga N; Utsunomiya H; Miki Y; Nagase S; Kobayashi R; Matsumoto M; Niikura H; Ito K; Yaegashi N
Clin Cancer Res; 2009 Oct; 15(19):6028-34. PubMed ID: 19789322
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells.
Wosikowski K; Küng W; Hasmann M; Löser R; Eppenberger U
Int J Cancer; 1993 Jan; 53(2):290-7. PubMed ID: 8425767
[TBL] [Abstract][Full Text] [Related]
4. Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2.
He YY; Du GQ; Cai B; Yan Q; Zhou L; Chen XY; Lu W; Yang YX; Wan XP
J Cancer Res Clin Oncol; 2012 May; 138(5):775-83. PubMed ID: 22270964
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-A.
Bergman CA; Talavera F; Christman GM; Baker VV; Roberts JA; Menon KM
Gynecol Oncol; 1997 Apr; 65(1):63-8. PubMed ID: 9103392
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of DNA synthesis and c-fos mRNA expression in primary rat hepatocytes by estrogens.
Lee CH; Edwards AM
Carcinogenesis; 2001 Sep; 22(9):1473-81. PubMed ID: 11532870
[TBL] [Abstract][Full Text] [Related]
7. Differential EGF action on nuclear protooncogenes in human endometrial carcinoma RL95-2 cells.
Sallot M; Ordener C; Lascombe I; Propper A; Adessi GL; Jouvenot M
Anticancer Res; 1996; 16(1):401-6. PubMed ID: 8615644
[TBL] [Abstract][Full Text] [Related]
8. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
9. Promoter-specific activation of mouse lactoferrin gene by epidermal growth factor involves two adjacent regulatory elements.
Shi H; Teng C
Mol Endocrinol; 1996 Jun; 10(6):732-41. PubMed ID: 8776733
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of epidermal growth factor and fetal calf serum in human endometrial carcinoma RL95-2 cells.
Sallot M; Lascombe I; Bermont L; Jouvenot M
Anticancer Res; 1997; 17(5A):3499-504. PubMed ID: 9413194
[TBL] [Abstract][Full Text] [Related]
11. Induction of c-fos/c-myc expression by epidermal growth factor decreases with alteration of their gene binding proteins in senescent fibroblasts.
Mao Z; Zhang Z; Tong T
Chin Med J (Engl); 1997 Oct; 110(10):755-9. PubMed ID: 9642304
[TBL] [Abstract][Full Text] [Related]
12. Expression of c-myc, epidermal growth factor receptor and c-erbB-2 in human endometrial carcinoma and cervical adenocarcinoma.
Sato S; Ito K; Ozawa N; Yajima A; Sasano H
Tohoku J Exp Med; 1991 Oct; 165(2):137-45. PubMed ID: 1687493
[TBL] [Abstract][Full Text] [Related]
13. Value of glutathione S-transferase pi and the oncogene products c-Jun, c-Fos, c-H-Ras, and c-Myc as a prognostic indicator in endometrial carcinomas.
Yokoyama Y; Sagara M; Sato S; Saito Y
Gynecol Oncol; 1998 Mar; 68(3):280-7. PubMed ID: 9570981
[TBL] [Abstract][Full Text] [Related]
14. Clinical implication of fos and jun expressions and protein kinase activity in endometrial cancers.
Fujimoto J; Hori M; Ichigo S; Morishita S; Tamaya T
Eur J Gynaecol Oncol; 1995; 16(2):138-46. PubMed ID: 7641741
[TBL] [Abstract][Full Text] [Related]
15. Expression of the proto-oncogenes c-fos and c-myc in mdx dystrophic mouse muscle.
Veal EA; Jackson MJ
Biochem Soc Trans; 1995 Feb; 23(1):131S. PubMed ID: 7758695
[No Abstract] [Full Text] [Related]
16. Estrogen induces expression of c-fos and c-jun via activation of protein kinase C in an endometrial cancer cell line and fibroblasts derived from human uterine endometrium.
Fujimoto J; Hori M; Ichigo S; Morishita S; Tamaya T
Gynecol Endocrinol; 1996 Apr; 10(2):109-18. PubMed ID: 8701784
[TBL] [Abstract][Full Text] [Related]
17. Krüppel-like factor 9 loss-of-expression in human endometrial carcinoma links altered expression of growth-regulatory genes with aberrant proliferative response to estrogen.
Simmons CD; Pabona JM; Heard ME; Friedman TM; Spataro MT; Godley AL; Simmen FA; Burnett AF; Simmen RC
Biol Reprod; 2011 Aug; 85(2):378-85. PubMed ID: 21543766
[TBL] [Abstract][Full Text] [Related]
18. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers.
Gründker C; Völker P; Schulz KD; Emons G
Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802
[TBL] [Abstract][Full Text] [Related]
19. The association between c-fos and c-jun expression and estrogen and progesterone receptors is lost in human endometrial cancer.
Salmi A; Carpén O; Rutanen E
Tumour Biol; 1999; 20(4):202-11. PubMed ID: 10393530
[TBL] [Abstract][Full Text] [Related]
20. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
